Guangxi LiuYao Group Co Ltd
SSE:603368
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
G
|
Guangxi LiuYao Group Co Ltd
SSE:603368
|
7.1B CNY |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
115.9B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.4B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
70.2B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
52.1B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.8B AUD |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.6B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.1B CNY |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Guangxi LiuYao Group Co Ltd
Glance View
Guangxi LiuYao Group Co Ltd, nestled in the lush landscapes of southern China, draws its origin from the age-old traditions that define the region’s rich heritage. This company, renowned for its deep-rooted expertise, specializes in the production of traditional Chinese medicines and healthcare products. Utilizing a blend of modern technology and ancient wisdom, LiuYao crafts remedies that resonate with the holistic approach cherished in Eastern medicine. The company harnesses the abundant resources of Guangxi's natural surroundings, where access to a diverse array of medicinal plants and herbs aids in the development of potent formulations. By marrying these natural elements with advanced scientific research and development, Guangxi LiuYao stands out in the crowded pharmaceutical market, maintaining a legacy of trust and efficacy among its consumers. In the competitive arena of healthcare, Guangxi LiuYao Group Co Ltd has carved a niche through its robust distribution strategies and insightful marketing practices. Their business model intricately weaves together local understanding and international ambition, allowing them to penetrate both domestic and foreign markets effectively. Retail chains, pharmacies, and hospitals across China form the backbone of their distribution network, ensuring their products reach a broad demographic. Additionally, through strategic partnerships and exports, LiuYao aligns itself with global healthcare trends, exploring opportunities in regions appreciative of alternative medicine. This dual approach of leveraging heritage and embracing modern market dynamics fuels their revenue, positioning Guangxi LiuYao favorably within the evolving landscape of global healthcare enterprises.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Guangxi LiuYao Group Co Ltd is 3.7%, which is below its 3-year median of 4%.
Over the last 3 years, Guangxi LiuYao Group Co Ltd’s Net Margin has increased from 3.5% to 3.7%. During this period, it reached a low of 3.5% on Sep 30, 2022 and a high of 4.2% on Sep 30, 2024.